Complicating autoimmune diseases in myasthenia gravis: a review
Myasthenia gravis (MG) is a rare autoimmune disease of skeletal muscle endplates. MG
subgroup is relevant for comorbidity, but usually not accounted for. MG patients have an …
subgroup is relevant for comorbidity, but usually not accounted for. MG patients have an …
Thymoma related myasthenia gravis in humans and potential animal models
A Marx, S Porubsky, D Belharazem… - Experimental …, 2015 - Elsevier
Thymoma-associated Myasthenia gravis (TAMG) is one of the anti-acetylcholine receptor
MG (AChR-MG) subtypes. The clinico-pathological features of TAMG and its pathogenesis …
MG (AChR-MG) subtypes. The clinico-pathological features of TAMG and its pathogenesis …
Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis
PMR Cruz, M Al-Hajjar, S Huda, L Jacobson… - JAMA …, 2015 - jamanetwork.com
Importance Cell-based assays (CBAs) were shown to improve detection of acetylcholine
receptor (AChR) antibodies in patients with myasthenia gravis (MG). Herein, we asked …
receptor (AChR) antibodies in patients with myasthenia gravis (MG). Herein, we asked …
MuSK autoantibodies in myasthenia gravis detected by cell based assay—a multinational study
AI Tsonis, P Zisimopoulou, K Lazaridis, J Tzartos… - Journal of …, 2015 - Elsevier
Seronegative myasthenia gravis (MG) presents a serious gap in MG diagnosis and
understanding. We applied a cell based assay (CBA) for the detection of muscle specific …
understanding. We applied a cell based assay (CBA) for the detection of muscle specific …
[HTML][HTML] Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK
Neuromuscular transmission failure in myasthenia gravis (MG) is most commonly elicited by
autoantibodies (ab) to the acetylcholine receptor or the muscle-specific kinase, constituting …
autoantibodies (ab) to the acetylcholine receptor or the muscle-specific kinase, constituting …
[HTML][HTML] Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis
M Marino, F Scuderi, D Samengo, G Saltelli, MT Maiuri… - PloS one, 2015 - journals.plos.org
Background Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients
have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while …
have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while …
重症肌无力免疫学机制研究进展
李媛， 楚兰， 张艺凡 - 中国神经免疫学和神经病学杂志, 2015 - cqvip.com
重症肌无力(MG) 是一种神经肌肉接头(NMJ) 传递障碍的获得性自身免疫性疾病,
发病机制主要以体液免疫为主, 细胞免疫依赖及补体参与. 研究表明, MG 的发病与多种淋巴细胞 …
发病机制主要以体液免疫为主, 细胞免疫依赖及补体参与. 研究表明, MG 的发病与多种淋巴细胞 …
Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of Mu SK myasthenia gravis
N Ghazanfari, ELTB Linsao, S Trajanovska… - Physiological …, 2015 - Wiley Online Library
We investigated the influence of postsynaptic tyrosine kinase signaling in a mouse model of
muscle‐specific kinase (Mu SK) myasthenia gravis (MG). Mice administered repeated daily …
muscle‐specific kinase (Mu SK) myasthenia gravis (MG). Mice administered repeated daily …
Characteristics of myasthenia gravis with antibodies to muscle‐specific kinase and low‐density lipoprotein‐related receptor protein 4
A Evoli, R Iorio - Clinical and Experimental Neuroimmunology, 2015 - Wiley Online Library
Myasthenia gravis (MG) is characterized by fatigable weakness of voluntary muscles caused
by immunoglobulin G autoantibodies binding to post‐synaptic proteins at the neuromuscular …
by immunoglobulin G autoantibodies binding to post‐synaptic proteins at the neuromuscular …
重症肌无力诊断与治疗最新进展
刘书平， 李承晏 - 卒中与神经疾病, 2015 - cqvip.com
重症肌无力(myasthenia gravis, MG) 是一种神经肌肉接头传递障碍疾病, 以骨骼肌无力,
晨轻暮重, 症状有波动为主要临床特点. 近年来老年MG 的发病率逐年增加 …
晨轻暮重, 症状有波动为主要临床特点. 近年来老年MG 的发病率逐年增加 …